anmelden
SPI
18.574,54
PKT
-62,04
PKT
-0,33
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.01.15 | Novartis Halten | Independent Research GmbH | |
| 27.01.15 | Nestlé Neutral | UBS AG | |
| 27.01.15 | UBS Hold | Jefferies & Company Inc. | |
| 27.01.15 | Nestlé Underperform | BNP PARIBAS | |
| 27.01.15 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.15 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 26.01.15 | Swiss Re Neutral | UBS AG | |
| 26.01.15 | Givaudan Neutral | Citigroup Corp. | |
| 26.01.15 | Holcim Neutral | BNP PARIBAS | |
| 26.01.15 | UBS Underweight | JP Morgan Chase & Co. | |
| 26.01.15 | UBS overweight | JP Morgan Chase & Co. | |
| 26.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.01.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.15 | ABB (Asea Brown Boveri) Neutral | Credit Suisse Group | |
| 26.01.15 | Givaudan Neutral | Nomura | |
| 26.01.15 | Swiss Re Underperform | BNP PARIBAS | |
| 23.01.15 | UBS buy | Citigroup Corp. | |
| 23.01.15 | UBS buy | Deutsche Bank AG | |
| 23.01.15 | UBS buy | Deutsche Bank AG | |
| 23.01.15 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.01.15 | UBS buy | Citigroup Corp. | |
| 23.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.01.15 | Roche Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis Outperform | BNP PARIBAS | |
| 22.01.15 | Novartis buy | UBS AG | |
| 22.01.15 | Roche Neutral | UBS AG | |
| 22.01.15 | Swiss Re neutral | Barclays Capital | |
| 22.01.15 | Zurich Insurance Equal weight | Barclays Capital | |
| 22.01.15 | UBS Halten | Bankhaus Lampe KG | |
| 22.01.15 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 22.01.15 | Holcim buy | Jefferies & Company Inc. | |
| 22.01.15 | Holcim Underweight | HSBC | |
| 21.01.15 | Novartis neutral | Morgan Stanley | |
| 21.01.15 | UBS Neutral | UBS AG | |
| 21.01.15 | Holcim Neutral | BNP PARIBAS | |
| 21.01.15 | Holcim Neutral | BNP PARIBAS | |
| 21.01.15 | UBS neutral | Independent Research GmbH | |
| 21.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 21.01.15 | Givaudan Outperform | Credit Suisse Group |